Just another reminder that the deadline for this awesome opportunity is coming up! Thanks, TF On Sep 13, 2012, at 9:58 AM, Nathan Wanderman wrote: > Hey AMSA members, I attended this last year and had a wonderful > time. I highly recommend taking advantage of this great opportunity: > > Pharmaceutical Policy Leadership in Medicine Institute > November 30 - December 2, 2012 > AMSA National Office > Application Deadline: September 27, 2012 > > For years, the pharmaceutical and device industry have shared a > collaborative relationship with academic medical centers leading to > major advances in the research and development of diagnostic and > therapeutic treatments. While such relationships have led to > significant contributions in the field of medicine, there has also > been growing concern amongst patients, politicians, providers and > medical students over the real and perceived conflicts of interest > that have become commonplace. According to a study published in the > Archives of Internal Medicine, over 84% of reported industry > relationships. Another study from the Pew Prescription Project > showed that 69% of patients felt like their doctor was “too > influenced” by pharmaceutical companies. > > In order to restore this eroded trust that is at the foundation of > the doctor-patient relationship, healthcare professionals including > future physicians have been instrumental in ensuring that medical > schools and academic medical centers adopt strong standards on > industry relationships. Medical students from AMSA’s PharmFree > Campaign with the Pew Prescription Project then created the AMSA > PharmFree Scorecard in an effort to highlight schools’ strong > policies and encourage others with weaker policies to create change > to ensure that their students were receiving evidence-based medical > education, rather than marketing-based medical education. > > Additionally, based on the recommendations from the American > Association of Medical Colleges and the Institute for Medicine, the > PharmFree Campaign created a Model Curriculum in order for students > to fully understand the consequences of such relationships between > industry and medicine. AMSA also offers the key components of this > curriculum through a 3-day institute as a way to train > undergraduate, graduate, and medical students to become of change in > pharmaceutical policy at not only their institutions, but also > nationally and internationally. Through expert speaker sessions, > participants will learn to use a range of transparency tools and > advocacy tactics to strategically design and implement campaigns > centered on current pharmaceutical policy issues. Experiences will > include talks by FDA policy makers, talks from grant partners at Pew > Charitable Trusts, National Physicians Alliance and Community > Catalyst, and workshops with student leadership on implementing > projects at your medical school. Participants will also receive > microgrants to implement these projects at their schools. > > *Apply now and AMSA will cover food, lodging, and tuition costs > courtesy of a grant from the State Attorney General Consumer and > Prescriber Education Grant Program which is funded by the multi- > state settlement of consumer fraud claims regarding the marketing of > the prescription drug Neurontin.* > > > > > Contact me with questions! > Ted Fagrelius, MS3